Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients

Nephrology

Volumn 15, Issue 3, 2010, Pages 368-376

  Lim, Wai H ^a,b   Chadban, Steve J ^b,e   Campbell, Scott ^b,f   Dent, Hannah ^c   Russ, Graeme R ^b,c,d   McDonald, Stephen P ^b,c,d  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

ANZDATA registry; Cyclosporine; IL 2 receptor antibody; Intermediate risk; Kidney transplant; Low risk

Indexed keywords

CYCLOSPORIN; HLA ANTIGEN; INTERLEUKIN 2 RECEPTOR ANTIBODY; PANEL REACTIVE ANTIBODY; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

ADULT; ANTIBODIES; AUSTRALIA; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; LINEAR MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTORS, INTERLEUKIN-2; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77950475613     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01259.x     Document Type: Article

References (21)

1. Chang S, Russ G, Chadban S, Campbell S, McDonald S. Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation 2007 84 : 611 618.
2. McDonald S, Russ G, Campbell S, Chadban S. Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome. Am. J. Transplant. 2007 7 : 1201 1208.
3. Boggi U, Vistoli F, Signori S et al. Efficacy and safety of basiliximab in kidney transplantation. Expert Opin. Drug Saf. 2005 4 : 473 490.
4. Ramirez C, Marino I. The role of basiliximab induction therapy in organ transplantation. Expert Opin. Biol. Ther. 2007 7 : 137 148.
5. Webster A, Playford E, Higgins G, Chapman J, Craig T. Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials. Transplantation 2004 77 : 166 176.
6. Keown P, Balshaw R, Khorasheh S et al. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation. BioDrugs 2003 17 : 271 279.
7. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005 80 : 1233 1243.
8. Andres A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit. Rev. Oncol. Hematol. 2005 56 : 71 85.
9. Brennan D, Daller J, Lake K, Cibrik D, Del Castillo D, for the Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N. Engl. J. Med. 2006 355 : 1967 1977.
10. Nashan B, Moore R, Amlot P, Schmidt A, Abeywickrama K, Soulillou J. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997 350 : 1193 1198. (Pubitemid 127445091)
11. Chang S, Russ G, Chadban S, Campbell S, McDonald S. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005. Nephrology 2008 13 : 171 176.
12. Ponticelli C, Yussim A, Cambi V et al. A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients. Transplantation 2001 72 : 1261 1267.
13. Nashan B. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: A comparative review. BioDrugs 2005 19 : 39 46.
14. Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999 130 : 461 470.
15. Lawen J, Davies E, Mourad G et al. Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation. Transplantation 2003 75 : 37 43. (Pubitemid 36139692)
16. Kahan B, Rajagopalan P, Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation 1999 67 : 276 284. (Pubitemid 29066355)
17. Opelz G, Naujokat C, Daniel V, Terness P, Döhler B. Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation 2006 81 : 1227 1233. (Pubitemid 43804539)
18. Willoughby L, Schnitzler M, Brennan D et al. Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: Application of statistical approaches to reduce bias in observational comparisons. Transplantation 2009 87 : 1520 1529.
19. Arnol M, Prather J, Mittalhenkle A, Barry J, Norman D. Long-term kidney regraft survival from deceased donors: Risk factors and outcomes in a single center. Transplantation 2008 86 : 1084 1089.
20. Premasathian N, Panorchan K, Vongwiwatana A, Pornpong C, Agadmeck S, Vejbaesya S. The effect of peak and current serum panel-reactive antibody on graft survival. Transplant. Proc. 2008 40 : 2200 2201.
21. Lim W, Chang S, Coates P, McDonald S. Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration rates. Transplantation 2007 84 : 972 980. (Pubitemid 350287378)